CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,712,859
- in 10 filings, $1.0M under 10b5-1 plans
Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 50 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-30 | Hansen Gwenn Chief Scientific Officer | Sale | −2,007 | $12.04 | $24K | 39,601 |
| 2024-04-30 | Hansen Gwenn Chief Scientific Officer | Option exercise · Restricted Stock Units | −3,206 | 22,448 | ||
| 2024-04-30 | Hansen Gwenn Chief Scientific Officer | Option exercise · Restricted Stock Units | −2,000 | 16,000 | ||
| 2024-04-30 | Ring Christine Chief Legal Officer | Option exercise | +1,924 | 19,351 | ||
| 2024-04-30 | Ring Christine Chief Legal Officer | Option exercise | +2,000 | 21,351 | ||
| 2024-04-30 | Ring Christine Chief Legal Officer | Sale | −1,513 | $12.04 | $18K | 19,838 |
| 2024-04-30 | Ring Christine Chief Legal Officer | Option exercise · Restricted Stock Units | −1,924 | 13,469 | ||
| 2024-04-30 | Ring Christine Chief Legal Officer | Option exercise · Restricted Stock Units | −2,000 | 16,000 | ||
| 2024-02-16 | van Houte Hans Chief Financial Officer | Sale 10b5-1 | −6,812 | $10.02 | $68K | 68,333 |
| 2024-02-13 | van Houte Hans Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2024-02-13 | van Houte Hans Chief Financial Officer | Grant or award · Restricted Stock Units | +45,000 | 45,000 | ||
| 2024-02-13 | Ring Christine Chief Legal Officer | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2024-02-13 | Ring Christine Chief Legal Officer | Grant or award · Restricted Stock Units | +45,000 | 45,000 | ||
| 2024-02-13 | Hansen Gwenn Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2024-02-13 | Hansen Gwenn Chief Scientific Officer | Grant or award · Restricted Stock Units | +45,000 | 45,000 | ||
| 2024-02-13 | SANDS ARTHUR T President, CEO | Grant or award · Employee Stock Option (right to buy) | +800,000 | 800,000 | ||
| 2024-01-30 | van Houte Hans Chief Financial Officer | Option exercise | +2,886 | 74,816 | ||
| 2024-01-30 | van Houte Hans Chief Financial Officer | Option exercise | +2,000 | 76,816 | ||
| 2024-01-30 | van Houte Hans Chief Financial Officer | Sale | −1,671 | $7.99 | $13K | 75,145 |
| 2024-01-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,886 | 23,089 |
Page 22 of 32 · 632 trades